These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31153594)

  • 21.
    Zhang F; Zhang C; Xu X; Zhang Y; Gong X; Yang Z; Zhang H; Tang D; Liang S; Liu Z
    J Biol Chem; 2019 May; 294(18):7324-7334. PubMed ID: 30804211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathic pain: models and mechanisms.
    Jarvis MF; Boyce-Rustay JM
    Curr Pharm Des; 2009; 15(15):1711-6. PubMed ID: 19442185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models of neuropathic pain.
    Jaggi AS; Jain V; Singh N
    Fundam Clin Pharmacol; 2011 Feb; 25(1):1-28. PubMed ID: 20030738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain.
    Rahman W; Dickenson AH
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):124-30. PubMed ID: 25730180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
    de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
    Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.
    Sawynok J
    Eur J Pain; 2014 Apr; 18(4):465-81. PubMed ID: 24108446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):71-8. PubMed ID: 20021340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
    Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
    J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Na
    Vetter I; Deuis JR; Mueller A; Israel MR; Starobova H; Zhang A; Rash LD; Mobli M
    Pharmacol Ther; 2017 Apr; 172():73-100. PubMed ID: 27916648
    [No Abstract]   [Full Text] [Related]  

  • 30. Challenges in the development of novel treatment strategies for neuropathic pain.
    Ossipov MH; Porreca F
    NeuroRx; 2005 Oct; 2(4):650-61. PubMed ID: 16489372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
    Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
    ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first clinical results obtained with a new analgesic--Promalgan.
    Bănescu O; Dumitrescu C; Mitu S; Dănău M
    Med Interne; 1982; 20(3):243-4. PubMed ID: 6760367
    [No Abstract]   [Full Text] [Related]  

  • 33. Translational Model Systems for Complex Sodium Channel Pathophysiology in Pain.
    Schrenk-Siemens K; Rösseler C; Lampert A
    Handb Exp Pharmacol; 2018; 246():355-369. PubMed ID: 29374838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging therapies for neuropathic pain: new molecules or new indications for old treatments?
    Bouhassira D; Attal N
    Pain; 2018 Mar; 159(3):576-582. PubMed ID: 29447137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models.
    Urru M; Muzzi M; Coppi E; Ranieri G; Buonvicino D; Camaioni E; Coppini R; Pugliese AM; Tanaka B; Estacion M; Waxman SG; Dib-Hajj SD; Chiarugi A
    Pain; 2020 Apr; 161(4):831-841. PubMed ID: 31815915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of neuropathic pain and their implications for the design of clinical trials.
    Rowbotham MC
    Neurology; 2005 Dec; 65(12 Suppl 4):S66-73. PubMed ID: 16385106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.
    Taneja A; Della Pasqua O; Danhof M
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current therapy of neuropathic pain].
    Schäfers M; Tölle TR
    Nervenarzt; 2013 Dec; 84(12):1445-50. PubMed ID: 24212417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodological issues associated with clinical trials in neuropathic pain.
    Gilron I
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1399-1402. PubMed ID: 27659719
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and Evaluation of Novel α-Aminoamides Containing an Indole Moiety for the Treatment of Neuropathic Pain.
    Li H; Fan S; Cheng J; Zhang P; Zhong B; Shi W
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.